Stock O'holics Investing University

[ddninja]

$PETV While the Gel-Del license included an option to merge, both parties agreed that an accelerated path to a merger would maximize shareholder value by providing a strategic inflection point that expands access to capital and accelerates commercialization of both human and animal devices. While this planned merger greatly expands our product pipeline, PetVivo remains committed to a Q4 2014 launch of our first product Kush™ for the treatment of animal lameness.